Correlation Between XORTX Therapeutics and Rakovina Therapeutics
Can any of the company-specific risk be diversified away by investing in both XORTX Therapeutics and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XORTX Therapeutics and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XORTX Therapeutics and Rakovina Therapeutics, you can compare the effects of market volatilities on XORTX Therapeutics and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XORTX Therapeutics with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of XORTX Therapeutics and Rakovina Therapeutics.
Diversification Opportunities for XORTX Therapeutics and Rakovina Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between XORTX and Rakovina is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding XORTX Therapeutics and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and XORTX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XORTX Therapeutics are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of XORTX Therapeutics i.e., XORTX Therapeutics and Rakovina Therapeutics go up and down completely randomly.
Pair Corralation between XORTX Therapeutics and Rakovina Therapeutics
Assuming the 90 days trading horizon XORTX Therapeutics is expected to under-perform the Rakovina Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, XORTX Therapeutics is 1.47 times less risky than Rakovina Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Rakovina Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 8.00 in Rakovina Therapeutics on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Rakovina Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
XORTX Therapeutics vs. Rakovina Therapeutics
Performance |
| Timeline |
| XORTX Therapeutics |
| Rakovina Therapeutics |
XORTX Therapeutics and Rakovina Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with XORTX Therapeutics and Rakovina Therapeutics
The main advantage of trading using opposite XORTX Therapeutics and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XORTX Therapeutics position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.The idea behind XORTX Therapeutics and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Rakovina Therapeutics vs. iShares Canadian HYBrid | Rakovina Therapeutics vs. Brompton European Dividend | Rakovina Therapeutics vs. Solar Alliance Energy | Rakovina Therapeutics vs. PHN Multi Style All Cap |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |